Tocagen (TOCA) Reports Early Completion of Enrollment in Toca 5 Pivotal Phase 3 Brain Cancer Trial

September 19, 2018 8:02 AM

Tocagen Inc. (NASDAQ: TOCA) today announced that it has completed the planned enrollment of 380 patients in the global Toca ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found